$103.00
0.890.87%
Last update: Nov 10, 3:23 PM
HealthEquity Inc
HQYNASDAQ
The average analyst price target for HealthEquity is $116.35, 13.0% above the current price. Of 17 analysts, 16 rate it Buy and 1 Sell. Targets range from $89 to $142. The latest change came on Oct 21, 2026, when BMO Capital raised its price target on HealthEquity from $105 to $125 and kept an Outperform rating.
Price Target Range — 13 Quarters
Analyst Consensus — 17 Analysts
Rating Trend — Last 9 Months
